DA Davidson Upgrades Martek Biosciences (MATK) to Neutral, $22 Price Target
Tweet Send to a Friend
DA Davidson has upgraded shares of Martek Biosciences (Nasdaq: MATK) from Underperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


